Experts in recruiting patients and running clinical trials - an exemplar SMO model
"We are a team of experienced clinical trial specialists who have held very senior roles in organisations which have pioneered the recruitment and running of clincial trials across the world."
Dr. Ian Smith
Founder of Synexus & Co-Founder of Panthera Biopartners
Latest Panthera News
UK independent clinical trial sites running research on new medicines continue to prosper despite the decline at NHS sites
The independent Site Management Organisations (SMOs) which run clinical trials on behalf of the pharmaceutical industry continue to expand not only the number of trials being brought to the UK but also the number of patients enrolled.
New data show that the site management model reduces start-up times for a Phase II or Phase III clinical trial by up to nine months compared to UK public sites, representing billions in savings Panthera identifies likely patients seven months before public sector sites start planning their recruitment campaigns. The loss of nine months patent
Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe Panthera Biosciences (Panthera) has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment will allow Panthera to further grow its network of dedicated